Page 5 - Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Aug 17, 2025

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

114 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
690
Uni-Bio Science Group
HK$0.14-3.3%158.9%HK$865.8mn/aPE10.5xn/a1.9%
2511
HighTide Therapeutics
HK$3.323.4%118.4%HK$1.9bn/aPB4.1xn/an/a
9966
Alphamab Oncology
HK$9.00-1.1%254.3%HK$8.7bHK$7.22PE48.2xn/an/a
8225
China Health Group
HK$0.185.3%92.5%HK$178.2mn/aPS6.2xn/an/a
455
Tianda Pharmaceuticals
HK$0.1910.6%-14.5%HK$404.2mn/aPS1.2xn/a0%
2898
Sunho Biologics
HK$6.90-5.2%7.3%HK$1.0bn/aPS25104xn/an/a
8329
Shenzhen Neptunus Interlong Bio-technique
HK$0.16-0.6%10.3%HK$268.5mn/aPE9.8xn/a3.3%
8247
Biosino Bio-Technology and Science Incorporation
HK$0.9511.8%61.0%HK$137.5mn/aPB0.8xn/a0%
9887
Nanjing Leads Biolabs
HK$69.354.3%n/aHK$13.4bn/aPB63.9xn/an/a
1875
BioDlink International
HK$2.36-0.4%30.4%HK$1.8bn/aPE230.5xn/an/a
6998
Genor Biopharma Holdings
HK$3.733.6%186.9%HK$1.9bn/aPS8.7xn/an/a
1652
Fusen Pharmaceutical
HK$0.359.2%-62.2%HK$262.5mn/aPB0.7xn/a0%
950
Lee's Pharmaceutical Holdings
HK$2.1525.0%82.2%HK$1.3bn/aPE13.6xn/a2.3%
2509
Qyuns Therapeutics
HK$22.468.5%-6.4%HK$5.0bn/aPS14.3xn/an/a
2627
Ab&B Bio-Tech JS
HK$47.18n/an/aHK$18.6bn/aPS65.6xn/an/a
2181
Mabpharm
HK$0.7427.6%102.7%HK$3.1bn/aPS10.8xn/an/a
858
Extrawell Pharmaceutical Holdings
HK$0.137.5%258.3%HK$308.3mn/aPE1.4xn/an/a
2315
Biocytogen Pharmaceuticals (Beijing)
HK$24.64-2.5%296.1%HK$9.8bn/aPE269.2xn/an/a
Page 5 of 5